158 related articles for article (PubMed ID: 12597641)
1. Flow cytometric immunophenotyping of acute lymphoblastic leukemia: is the time ready for consensus the guidelines?
Basso G; Lanza F; Orfao A; Benè M; Borowitz M; Campana D; Lacombe F; Ludwig WD; Porwitt-MacDonald A; Rothe G; Dworzac M;
J Biol Regul Homeost Agents; 2002; 16(4):257-8. PubMed ID: 12597641
[No Abstract] [Full Text] [Related]
2. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis.
Rothe G; Schmitz G
Leukemia; 1996 May; 10(5):877-95. PubMed ID: 8656686
[TBL] [Abstract][Full Text] [Related]
3. AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of Pediatric acute lymphoblastic leukemia.
Dworzak MN; Buldini B; Gaipa G; Ratei R; Hrusak O; Luria D; Rosenthal E; Bourquin JP; Sartor M; Schumich A; Karawajew L; Mejstrikova E; Maglia O; Mann G; Ludwig WD; Biondi A; Schrappe M; Basso G;
Cytometry B Clin Cytom; 2018 Jan; 94(1):82-93. PubMed ID: 28187514
[TBL] [Abstract][Full Text] [Related]
4. First proposed panels on acute leukemia for four-color immunophenotyping by flow cytometry from the Brazilian group of flow cytometry-GBCFLUX.
Ikoma MR; Sandes AF; Thiago LS; Cavalcanti Júnior GB; Lorand-Metze IG; Costa ES; Pimenta G; Santos-Silva MC; Bacal NS; Yamamoto M; Souto EX;
Cytometry B Clin Cytom; 2015; 88(3):194-203. PubMed ID: 24753208
[TBL] [Abstract][Full Text] [Related]
5. Acute lymphoblastic leukemia.
Onciu M
Hematol Oncol Clin North Am; 2009 Aug; 23(4):655-74. PubMed ID: 19577163
[TBL] [Abstract][Full Text] [Related]
6. Flow-cytometric detection of minimal residual disease in adult acute lymphoblastic leukemia.
Krampera M; Perbellini O; Maggioni A; Scognamiglio F; Todeschini G; Pizzolo G
Haematologica; 2001 Mar; 86(3):322-3. PubMed ID: 11255283
[No Abstract] [Full Text] [Related]
7. Acute lymphoblastic leukemia.
Melnick SJ
Clin Lab Med; 1999 Mar; 19(1):169-86, vii. PubMed ID: 10403080
[TBL] [Abstract][Full Text] [Related]
8. Brazilian group of flow cytometry (GBCFLUX) panels for acute leukemia: Some insights.
Matos DM
Cytometry B Clin Cytom; 2015; 88(5):286-7. PubMed ID: 26235996
[No Abstract] [Full Text] [Related]
9. Acute lymphoblastic leukemia: diagnosis and detection of minimal residual disease following therapy.
Digiuseppe JA
Clin Lab Med; 2007 Sep; 27(3):533-49, vi. PubMed ID: 17658406
[TBL] [Abstract][Full Text] [Related]
10. Brazilian Group of Flow Cytometry (GBCFLUX) panels for acute leukemias--Response to Matos.
Ikoma MR; Sandes AF; Lorand-Metze IG; Yamamoto M
Cytometry B Clin Cytom; 2015; 88(5):288. PubMed ID: 25588574
[No Abstract] [Full Text] [Related]
11. Towards standardization in immunophenotyping hematological malignancies. How can we improve the reproducibility and comparability of flow cytometric results? Working Group on Leukemia Immunophenotyping.
Lanza F
Eur J Histochem; 1996; 40 Suppl 1():7-14. PubMed ID: 8839695
[No Abstract] [Full Text] [Related]
12. Philadelphia positive (Ph+) acute lymphoblastic leukemia (ALL) patient with breast infiltration.
Papayannidis C; Iacobucci I; Abbenante MC; Curti A; Parisi S; Paolini S; Testoni N; Baccarani M; Cilloni D; Martinelli G
Leuk Res; 2010 Sep; 34(9):e246-7. PubMed ID: 20381144
[No Abstract] [Full Text] [Related]
13. Routine immunophenotyping in acute leukemia: Role in lineage assignment and reassignment.
Qadir M; Barcos M; Stewart CC; Sait SN; Ford LA; Baer MR
Cytometry B Clin Cytom; 2006 Sep; 70(5):329-34. PubMed ID: 16739218
[TBL] [Abstract][Full Text] [Related]
14. Transfer of genomics information to flow cytometry: expression of CD27 and CD44 discriminates subtypes of acute lymphoblastic leukemia.
Vaskova M; Mejstrikova E; Kalina T; Martinkova P; Omelka M; Trka J; Stary J; Hrusak O
Leukemia; 2005 May; 19(5):876-8. PubMed ID: 15759032
[No Abstract] [Full Text] [Related]
15. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: medical indications.
Davis BH; Foucar K; Szczarkowski W; Ball E; Witzig T; Foon KA; Wells D; Kotylo P; Johnson R; Hanson C; Bessman D
Cytometry; 1997 Oct; 30(5):249-63. PubMed ID: 9383099
[No Abstract] [Full Text] [Related]
16. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
DiGiuseppe JA; Fuller SG; Borowitz MJ
Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
[TBL] [Abstract][Full Text] [Related]
17. Unnecessary emphasis on blast morphology in an inadequately worked up case of acute leukemia.
Parikh PM; Barbhaya SA; Bajpai S; Goyal R; Chopra HK
J Assoc Physicians India; 1995 Feb; 43(2):145. PubMed ID: 9282691
[No Abstract] [Full Text] [Related]
18. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data reporting.
Braylan RC; Atwater SK; Diamond L; Hassett JM; Johnson M; Kidd PG; Leith C; Nguyen D
Cytometry; 1997 Oct; 30(5):245-8. PubMed ID: 9383098
[No Abstract] [Full Text] [Related]
19. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia.
Wood BL; Arroz M; Barnett D; DiGiuseppe J; Greig B; Kussick SJ; Oldaker T; Shenkin M; Stone E; Wallace P
Cytometry B Clin Cytom; 2007; 72 Suppl 1():S14-22. PubMed ID: 17803189
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotyping and immunoglobulin heavy chain gene rearrangement analysis in cerebrospinal fluid of pediatric patients with acute lymphoblastic leukemia.
Sayed D; Badrawy H; Ali AM; Shaker S
Leuk Res; 2009 May; 33(5):655-61. PubMed ID: 18996593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
